Metabolic Health
Lilly Reports Retatrutide Outperformed Ozempic 2 mg in a Phase 3 Diabetes Trial
Lilly reports greater blood-sugar and weight reductions with retatrutide than Ozempic 2 mg. The topline results concern diabetes, not longevity; retatrutide remains…